Human allogeneic vascular rejection after arterial transplantation and peripheral lymphoid reconstitution in severe combined immunodeficient mice

Transplantation

Volumn 67, Issue 6, 1999, Pages 897-903

  Lorber, Marc I ^a   Wilson, Jean H ^a   Robert, Marie E ^a   Schechner, Jeffrey S ^a,b   Kirkiles, Nancy ^a,b   Qian, He Ying ^a   Askenase, Phillip W ^a   Tellides, George ^a,b   Pober, Jordan S ^a,b  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOGRAFT; ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; ARTERY TRANSPLANTATION; ARTICLE; COMBINED IMMUNODEFICIENCY; GRAFT REJECTION; HUMAN; HUMAN TISSUE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; VASCULAR SMOOTH MUSCLE;

EID: 0033608755     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199903270-00018     Document Type: Article

References (31)

1. van Saase JLCM, van Der Woude FJ, Thorogood J, et al. The relation between acute vascular and interstitial renal allograft rejection and subsequent chronic rejection. Transplantation 1995; 59: 1280.
2. Paul LC. Aspects of allograft rejection, clinical assessment of renal allograft rejection. Transplant Rev 1995; 9: 127.
3. Tilney NL, Whitley WD, Diamond JR, Kupiec-Weglinski JW, Adams DH. Chronic rejection: an undefined conundrum. Transplantation 1991; 52: 389.
4. Solez K. International standardization of criteria for histologic diagnosis of chronic rejection in renal allografts. Clin Transplant 1994; 8: 345.
5. Murray AG, Petzelbauer P, Hughes CCW, Costa J, Askenase P, Pober JS. Human T cell mediated destruction of allogeneic dermal microvessels in a SCID mouse. Proc Natl Acad Sei USA 1994; 91: 9146.
6. Murray AG, Schechner J, Epperson DE, et al. Microvascular injury in the huPBL SCID mouse/skin allograft model is T cell mediated and inhibited by cyclosporine and rapamycin. Am J Pathol 1998; 153: 627.
7. Hancock W, Whitley WD, Tullius SG, et al. Cytokines, adhesion molecules and the pathogenesis of chronic rejection of rat renal allografts. Transplantation 1993; 56: 643.
8. Mennander A, Tiisala S, Halttunen J, Yilmaz S, Paavonen T, Hayry P. Chronic rejection in rat aortic allografts: an experimental model for transplant arteriosclerosis. Arterioscler Thromb 1991; 11: 671.
9. Shi C, Russell ME, Bianchi C, Newell JB, Haber E. Murine model of accelerated transplant arteriosclerosis. Circ Res 1994; 75: 199.
10. Tullius SG, Hancock WW, Heeman U, Azuma H, Tilney NL. Reversibility of chronic renal allograft rejection. Transplantation 1994; 58: 93.
11. Menander A, Hayry P. Reversibility of allograft arteriosclerosis after retransplantation to donor strain. Transplantation 1996; 62: 526.
12. Subbotin V, Sun H, Aitouche A, et al. Abrogation of chronic rejection in a murine model of aortic allotransplantation by prior induction of donor-specific tolerance. Transplantation 1997; 64: 690.
13. Fabre JW, Barclay AN, Mason DW. Class II major histocompatibility complex antigens expressed on blood vascular endothelial cells [Letter]. Transplantation 1983; 36: 596.
14. Ferry B, Halttunen J, Leszcynski D, Schellekens H, v.d. Meide PH, Hayry P. Impact of class II major histocompatibility complex antigen expression on the immunogenic potential of isolated rat vascular endothelial cells. Transplantation 1987; 44: 499.
15. Murray AS, Khodadoust MM, Pober JS, Bothwell AL. Porcine aortic endothelia cells activate human T cells: direct presentation of MHC antigens and costimulation by ligands for human CD2 and CD28. Immunity 1994; 1: 57.
16. Sultan P, Schechner JS, McNiff JM, et al. Blockade of CD2-LFA3 interactions protects human skin allografts in immunodefi-cient mouse/human chimeras. Nat Biotechnol 1997; 15: 759.
17. Solez K, Axelsen RA, Benediktsson H, et al. International standardization of nomenclature and criteria for the histologic diagnosis of renal allograft rejection: the Banff working classification of kidney transplant pathology. Kidney Int 1993; 44: 411.
18. Groenewegen F, Buurman WA, vander Linden CJ. Lymphokine dependence of in vivo expression of MHC class II antigens by endothelium. Nature 1985; 316: 361.
19. Pober JS, Orosz CG, Rose ML, Savage CO. Can graft endothelial cells initiate a host anti-graft immune response? Transplantation 1996; 61: 343.
20. Hruban RH, Beschomer WE, Baumgartner WA, et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T lymphocyte-mediated endothelialitis. Am J Pathol 1990; 137: 871.
21. Salomon RN, Hughes CCW, Shoen FJ, et al. Human coronary transplantation-associated arteriosclerosis. Am J Pathol 1991; 138: 791.
22. Shi E, Lee W-S, He Q, et al. Immunologic basis of transplant-associated arteriosclerosis. Proc Natl Acad Sci USA 1996; 93: 4051.
23. Chavin KD, Lau HT, Bromberg JS. Prolongation of allograft and xenograft survival in mice by anti-CD2 monoclonal antibodies. Transplantation 1992; 54: 286.
24. Lenschow DJ, Zeng Y, Thistlethwaite JR, Bluestone J. Long term survival of xenogeneic pancreatic islet grafts induced by CTLA-4. Science 1992; 257: 789.
25. Lin H, Boiling SF, Linsley PS. Long-term acceptance of major histocompatibility mismatched cardiac allografts induced by CTLA4Ig plus donor-specific transfusion. J Exp Med 1993; 178: 1801.
26. Woodward JE, Lihui Q, Chavin K, et al. Blockade of multiple costimulatory receptors induces hyporesponsiveness. Transplantation 1996; 62: 1011.
27. Krieger NR, Most D, Bromberg JS, et al. Coexistence of Th1-and Th2-type cytokine profiles in anti-CD2 monoclonal antibody-induced tolerance. Transplantation 1992; 62: 1285.
28. Shiroki R, Poindexter NJ, Woodle ES, et al. Human peripheral blood lymphocyte reconstituted SCID mice: a model for human islet allograft rejection. Transplantation 1994; 57: 1555.
29. Mackenzie DA, Sollinger HW, Hullett DA. Acute graft rejection of human fetal pancreas allografts using donor specific human PBL in the SCID mouse. Transplantation 1996; 61: 1461.
30. Alegre ML, Peterson LJ, Jeyarajah DR, et al. Severe combined immunodeficient mice engrafted with human splenocytes have functional human T cells and reject human allografts. J Immunol 1994; 153: 2738.
31. Meehan SM, McCluskey RT, Pascual M, et al. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP17 and cells with fragmented nuclear DNA. Lab Invest 1997; 76: 639.